Advertisement

Headache

  • Doris Kung
  • Thy Nguyen
  • Ritu Das
Chapter

Abstract

This chapter focuses on the classification, presentation, diagnosis, and treatment of common and less common headache types, such as migraines, trigeminal autonomic cephalgias, and secondary causes of headaches.

References

  1. Bagnato F, Good J. The use of antiepileptics in migraine prophylaxis. Headache. 2016;56(3):603–15.CrossRefGoogle Scholar
  2. Becker WJ. Acute migraine treatment in adults. [Review]. Headache. 2015;55(6):778–93.  https://doi.org/10.1111/head.12550.CrossRefPubMedGoogle Scholar
  3. Cheshire WP. Cranial neuralgias. Continuum (Minneap Minn). 2015;21(4):1072–85.Google Scholar
  4. Chou DE. Secondary headache syndromes. Continuum (Minneap Min). 2018;24(4, Headache):1179–91.Google Scholar
  5. Couch JR. Therapy of migraine, cluster, and tension headaches. In: Biller J, editor. Practical neurology. 3rd ed. Philadelphia: Lippincott Williams and Wilkins; 2009. p. 671–92.Google Scholar
  6. El-Dairi MA, et al. Diagnostic algorithm for patients with suspected giant cell arteritis. J Neuroophthalmol. 2015;35(3):246–53.CrossRefGoogle Scholar
  7. Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders. 3rd ed. Cephalalgia. 2018;38(1):1–211.CrossRefGoogle Scholar
  8. Hill T, Coupland C, Morriss R, Arthur A, Moore M, Hippisley-Cox J. Antidepressant use and risk of epilepsy and seizures in people aged 20 to 64 years: cohort study using a primary care database. BMC Psychiatry. 2015;15:315.CrossRefGoogle Scholar
  9. Joffe AR. Lumbar puncture and brain herniation in acute bacterial meningitis: a review. J Intensive Care Med. 2007;22(4):194–207.CrossRefGoogle Scholar
  10. Lawton MT, Vates GE. Subarachnoid hemorrhage. NEJM. 2017;377(3):257–66.CrossRefGoogle Scholar
  11. NORDIC Idiopathic Intracranial Hypertension Study Group Writing Committee, et al. Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial. JAMA. 2014;311(16):1641–51.CrossRefGoogle Scholar
  12. Pelzer N, Stam AH, Haan J, et al. Familial and sporadic hemiplegic migraine: diagnosis and treatment. Curr Treat Options Neurol. 2013;15:13–27.CrossRefGoogle Scholar
  13. Piper RJ, Kalyvas AV, et al. Interventions for idiopathic intracranial hypertension (Review). Cochrane Database of Syst Rev. 2015;(8):1–33.Google Scholar
  14. Rozen T. Emergency department and inpatient management of status migrainosus and intractable headache. Continuum (Minneap Minn). 2015;21(4):1004–17.Google Scholar
  15. Sclar DA, Robison LM, Castillo LV, et al. Concomitant use of Triptan, and SSRI or SNRI after the US food and drug administration alert on serotonin syndrome. Headache. 2012;52:198–203.CrossRefGoogle Scholar
  16. Silberstein SD. Preventative migraine treatment. Continuum (Minneap Minn). 2015;21(4):973–89.Google Scholar
  17. Silberstein SD, Olesen J, et al. The international classification of headache disorders, 2nd edition. Cephalgia. 2005;25:460–5.CrossRefGoogle Scholar
  18. Tepper SJ. Medication-overuse headache. [Case Reports Review]. Continuum (Minneap Minn). 2012;18(4):807–22.  https://doi.org/10.1212/01.CON.0000418644.32032.7b.CrossRefGoogle Scholar
  19. Wall M. Update on Idiopathic Intracranial Hypertension. Neurol Clin. 2017;35(1):45–57.CrossRefGoogle Scholar
  20. Woldeamanuel YW, Rapoport AM, Cowan RP. The place of corticosteroids in migraine attack management: a 65-year systematic review with pooled analysis and critical appraisal. Cephalalgia. 2015;35(11):996–1024.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Doris Kung
    • 1
  • Thy Nguyen
    • 2
  • Ritu Das
    • 3
  1. 1.Department of NeurologyBaylor College of MedicineHoustonUSA
  2. 2.Department of NeurologyThe University of Texas Health Science CenterHoustonUSA
  3. 3.Adventist HealthParadiseUSA

Personalised recommendations